v3.26.1
Segment Information - Schedule of Segment Revenue and Expenses (Details) - DiamiR Biosciences Corp. [Member] - USD ($)
6 Months Ended 9 Months Ended 12 Months Ended
Nov. 30, 2025
Feb. 28, 2026
Feb. 28, 2025
May 31, 2025
May 31, 2024
Segment Reporting Information [Line Items]          
Revenue   $ 190,355 $ 631,729 $ 631,729 $ 1,319,531
Research and development          
Research and development       650,591 1,156,860
Other R&D       2,236
General and administrative          
General and administrative       624,388 614,074
Patents       44,363 30,167
Depreciation   14,624 15,102 20,828 20,052
Offering costs       150,526
Rent and facilities       53,483 55,600
Other       35,918 86,204
Interest expense       82,046 48,599
Income taxes   $ (174,546) $ 14,346 17,939 114,403
Net loss $ (349,842)     (743,235) (614,405)
Salaries and benefits [Member]          
Research and development          
Research and development       449,344 692,875
General and administrative          
General and administrative       105,761 117,883
Consultants and contractors [Member]          
Research and development          
Research and development       176,935 278,837
General and administrative          
General and administrative       213,509 292,234
Stock based compensation [Member]          
Research and development          
Research and development       24,312 182,912
General and administrative          
General and administrative       $ 11,934